The ClearSEEK™ PIK3CA Panel is a specialized genetic testing kit for advanced HR+/HER2- breast cancer, focusing on 20 important PIK3CA gene variants. With high sensitivity, it detects mutations even at 1% allele frequency, using as little as 10 ng of DNA. Efficient in lab settings, the panel requires only 1 hour of hands-on time and provides results in 8 hours, supporting timely and informed decisions in clinical research and personalized treatment strategies.